Bastide Le Confort Médical Past Earnings Performance
Past criteria checks 1/6
Bastide Le Confort Médical has been growing earnings at an average annual rate of 4.4%, while the Healthcare industry saw earnings growing at 13% annually. Revenues have been growing at an average rate of 9.1% per year. Bastide Le Confort Médical's return on equity is 11.8%, and it has net margins of 1.4%.
Key information
4.4%
Earnings growth rate
4.1%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 9.1% |
| Return on equity | 11.8% |
| Net Margin | 1.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Bastide Le Confort Médical's (EPA:BLC) Soft Earnings Don't Show The Whole Picture
Nov 13
Investors Can Find Comfort In Bastide Le Confort Médical's (EPA:BLC) Earnings Quality
Apr 06Recent updates
Investors Appear Satisfied With Bastide Le Confort Médical SA's (EPA:BLC) Prospects As Shares Rocket 28%
Dec 12Bastide Le Confort Médical's (EPA:BLC) Soft Earnings Don't Show The Whole Picture
Nov 13Bastide Le Confort Médical SA (EPA:BLC) Just Reported, And Analysts Assigned A €28.17 Price Target
Oct 26We Like These Underlying Return On Capital Trends At Bastide Le Confort Médical (EPA:BLC)
Jun 14Bastide Le Confort Médical (EPA:BLC) Has A Somewhat Strained Balance Sheet
May 27Why Investors Shouldn't Be Surprised By Bastide Le Confort Médical SA's (EPA:BLC) 28% Share Price Surge
May 12Is Now An Opportune Moment To Examine Bastide Le Confort Médical SA (EPA:BLC)?
Apr 27Investors Can Find Comfort In Bastide Le Confort Médical's (EPA:BLC) Earnings Quality
Apr 06Benign Growth For Bastide Le Confort Médical SA (EPA:BLC) Underpins Stock's 26% Plummet
Mar 28Positive Sentiment Still Eludes Bastide Le Confort Médical SA (EPA:BLC) Following 28% Share Price Slump
Feb 08The Return Trends At Bastide Le Confort Médical (EPA:BLC) Look Promising
Nov 18What Is Bastide Le Confort Médical SA's (EPA:BLC) Share Price Doing?
May 17Bastide Le Confort Médical (EPA:BLC) Is Doing The Right Things To Multiply Its Share Price
Jan 27Is Bastide Le Confort Médical SA (EPA:BLC) Potentially Undervalued?
Nov 22Bastide Le Confort Médical (EPA:BLC) Is Reinvesting At Lower Rates Of Return
Sep 21Is It Time To Consider Buying Bastide Le Confort Médical SA (EPA:BLC)?
Jul 28When Should You Buy Bastide Le Confort Médical SA (EPA:BLC)?
Mar 18Be Wary Of Bastide Le Confort Médical (EPA:BLC) And Its Returns On Capital
May 16Here's Why Bastide Le Confort Médical (EPA:BLC) Has A Meaningful Debt Burden
Apr 30We Think Bastide Le Confort Médical's (EPA:BLC) Profit Is Only A Baseline For What They Can Achieve
Apr 07Should You Think About Buying Bastide Le Confort Médical SA (EPA:BLC) Now?
Mar 10Is Bastide Le Confort Médical SA's (EPA:BLC) 16% ROE Better Than Average?
Feb 21Bastide Le Confort Médical SA's (EPA:BLC) Intrinsic Value Is Potentially 33% Above Its Share Price
Feb 07
Revenue & Expenses Breakdown
How Bastide Le Confort Médical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 530 | 7 | 244 | 0 |
| 31 Mar 24 | 527 | 7 | 242 | 0 |
| 31 Dec 23 | 523 | 6 | 240 | 0 |
| 30 Sep 23 | 516 | 11 | 235 | 0 |
| 30 Jun 23 | 508 | 16 | 230 | 0 |
| 31 Dec 22 | 495 | 18 | 224 | 0 |
| 30 Sep 22 | 482 | 16 | 216 | 0 |
| 30 Jun 22 | 468 | 14 | 207 | 0 |
| 31 Dec 21 | 446 | 13 | 194 | 0 |
| 30 Sep 21 | 445 | 13 | 191 | 0 |
| 30 Jun 21 | 444 | 13 | 189 | 0 |
| 31 Mar 21 | 436 | 12 | 188 | 0 |
| 31 Dec 20 | 428 | 11 | 186 | 0 |
| 30 Sep 20 | 405 | 11 | 178 | 0 |
| 30 Jun 20 | 383 | 12 | 170 | 0 |
| 31 Mar 20 | 365 | 9 | 162 | 0 |
| 31 Dec 19 | 347 | 7 | 154 | 0 |
| 30 Sep 19 | 341 | 6 | 155 | 0 |
| 30 Jun 19 | 336 | 6 | 156 | 0 |
| 31 Mar 19 | 328 | 7 | 150 | 0 |
| 31 Dec 18 | 321 | 9 | 145 | 0 |
| 30 Sep 18 | 305 | 8 | 137 | 0 |
| 30 Jun 18 | 289 | 7 | 128 | 0 |
| 31 Mar 18 | 267 | 6 | 120 | 0 |
| 31 Dec 17 | 245 | 5 | 112 | 0 |
| 30 Sep 17 | 232 | 5 | 106 | 0 |
| 30 Jun 17 | 218 | 5 | 100 | 0 |
| 31 Mar 17 | 211 | 6 | 96 | 0 |
| 31 Dec 16 | 203 | 7 | 93 | 0 |
| 30 Sep 16 | 198 | 7 | 91 | 0 |
| 30 Jun 16 | 192 | 7 | 88 | 0 |
| 31 Mar 16 | 187 | 7 | 86 | 0 |
| 31 Dec 15 | 182 | 7 | 83 | 0 |
| 30 Sep 15 | 177 | 7 | 81 | 0 |
| 30 Jun 15 | 171 | 7 | 79 | 0 |
| 31 Mar 15 | 166 | 7 | 76 | 0 |
| 31 Dec 14 | 160 | 6 | 73 | 0 |
| 30 Sep 14 | 156 | 6 | 72 | 0 |
| 30 Jun 14 | 152 | 5 | 70 | 0 |
| 31 Mar 14 | 148 | 5 | 68 | 0 |
Quality Earnings: BLC has a large one-off loss of €5.3M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: BLC's current net profit margins (1.4%) are lower than last year (3.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BLC's earnings have grown by 4.4% per year over the past 5 years.
Accelerating Growth: BLC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: BLC had negative earnings growth (-54.1%) over the past year, making it difficult to compare to the Healthcare industry average (14.9%).
Return on Equity
High ROE: BLC's Return on Equity (11.8%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/01 07:35 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bastide Le Confort Médical SA is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robin Leclerc | Degroof Petercam |
| Guillaume Cuvillier | Gilbert Dupont |
| Murielle Andre-Pinard | HSBC |